tiprankstipranks
Advertisement
Advertisement

NKTX Stock Latest News

Nkarta price target lowered to $10 from $11 at Stifel
The FlyNkarta price target lowered to $10 from $11 at Stifel
6d ago
NKTX
Nkarta: Buy Rating Reiterated with Unchanged $11 Price Target on Solid Cash Runway and Advancing Trials
PremiumRatings
Nkarta: Buy Rating Reiterated with Unchanged $11 Price Target on Solid Cash Runway and Advancing Trials
11d ago
NKTX
Nkarta price target lowered to $14 from $16 at H.C. Wainwright
PremiumThe Fly
Nkarta price target lowered to $14 from $16 at H.C. Wainwright
11d ago
NKTX
Nkarta reports Q2 EPS (54c), consensus (36c)
PremiumThe Fly
Nkarta reports Q2 EPS (54c), consensus (36c)
12d ago
NKTX
Nkarta initiated with a Buy at TD Cowen
PremiumThe Fly
Nkarta initiated with a Buy at TD Cowen
2M ago
NKTX
Phil Nadeau Reiterates Buy on Nkarta, Citing Differentiated NK Cell Platform and CD19 CAR NK Therapy as Key Long-Term Value Drivers
PremiumRatingsPhil Nadeau Reiterates Buy on Nkarta, Citing Differentiated NK Cell Platform and CD19 CAR NK Therapy as Key Long-Term Value Drivers
2M ago
NKTX
Nkarta Shareholders Back Directors, Auditor and Annual Say-on-Pay
Premium
Company Announcements
Nkarta Shareholders Back Directors, Auditor and Annual Say-on-Pay
2M ago
8K
NKTX
Nkarta price target lowered to $9 from $25 at Evercore ISI
Premium
The Fly
Nkarta price target lowered to $9 from $25 at Evercore ISI
3M ago
NKTX
Nkarta Buy Rating Reaffirmed as NKX019 Autoimmune Trials Advance; $16 Price Target Maintained
PremiumRatings
Nkarta Buy Rating Reaffirmed as NKX019 Autoimmune Trials Advance; $16 Price Target Maintained
3M ago
NKTX
Nkarta reports Q1 EPS (37c), consensus (37c)
PremiumThe Fly
Nkarta reports Q1 EPS (37c), consensus (37c)
3M ago
NKTX
Nkarta (NKTX): Constructive Buy Rating on Leadership, Strategic Positioning, and Upcoming Value-Creating Milestones
PremiumRatings
Nkarta (NKTX): Constructive Buy Rating on Leadership, Strategic Positioning, and Upcoming Value-Creating Milestones
4M ago
NKTX
Nkarta announces agreement with FDA on changes to Ntrust-1, Ntrust-2 trials
PremiumThe Fly
Nkarta announces agreement with FDA on changes to Ntrust-1, Ntrust-2 trials
4M ago
NKTX
Nkarta price target lowered to $12 from $14 at Mizuho
PremiumThe FlyNkarta price target lowered to $12 from $14 at Mizuho
5M ago
NKTX
Buy Rating Initiated on NKX019’s Differentiated CAR‑NK Platform and De‑Risked Autoimmune Opportunity Ahead of 2026 Proof‑of‑Concept Data
Premium
Ratings
Buy Rating Initiated on NKX019’s Differentiated CAR‑NK Platform and De‑Risked Autoimmune Opportunity Ahead of 2026 Proof‑of‑Concept Data
5M ago
NKTX
Nkarta price target raised to $11 from $10 at Needham
Premium
The Fly
Nkarta price target raised to $11 from $10 at Needham
5M ago
NKTX
Nkarta Launches $100 Million At-the-Market Stock Offering
PremiumCompany Announcements
Nkarta Launches $100 Million At-the-Market Stock Offering
5M ago
8K
NKTX
Nkarta files $350M mixed securities shelf
PremiumThe Fly
Nkarta files $350M mixed securities shelf
5M ago
NKTX
Nkarta reports Q4 EPS (37c), consensus (29c)
PremiumThe Fly
Nkarta reports Q4 EPS (37c), consensus (29c)
5M ago
NKTX
Is NKTX a Buy, Before Earnings?
PremiumPre-Earnings
Is NKTX a Buy, Before Earnings?
5M ago
NKTX
Nkarta price target lowered to $11 from $12 at Stifel
PremiumThe FlyNkarta price target lowered to $11 from $12 at Stifel
9M ago
NKTX
Nkarta’s Strategic Management and Financial Strength Justify Buy Rating and $10 Target Price
Premium
Ratings
Nkarta’s Strategic Management and Financial Strength Justify Buy Rating and $10 Target Price
9M ago
NKTX
Nkarta Advances NKX019 Program Amid Financial Stability
Premium
Company Announcements
Nkarta Advances NKX019 Program Amid Financial Stability
9M ago
NKTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >